Emerging Concepts in Managing Malignancy in Kidney Transplant Patients

Brittany Schreiber, Maen Abdelrahim, Ala Abudayyeh, Naoka Murakami

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Cancer remains a significant cause of morbidity and mortality in kidney transplant recipients, due to long-term immunosuppression. Salient issues to consider in decreasing the burden of malignancy among kidney transplant recipients include pretransplant recipient evaluation, post-transplant screening and monitoring, and optimal treatment strategies for the kidney transplant recipients with cancer. In this review, we address cancer incidence and outcomes, approaches to cancer screening and monitoring pretransplant and post-transplant, as well as treatment strategies, immunosuppressive management, and multidisciplinary approaches in the kidney transplant recipients with cancer.

Original languageEnglish (US)
Pages (from-to)63-75
Number of pages13
JournalSeminars in nephrology
Issue number1
StatePublished - Jan 2022


  • Kidney transplant
  • PTLD
  • cancer
  • immunotherapy
  • oncology
  • wait time
  • Kidney Transplantation/adverse effects
  • Immunosuppressive Agents/adverse effects
  • Humans
  • Immunosuppression Therapy/adverse effects
  • Neoplasms/epidemiology

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Emerging Concepts in Managing Malignancy in Kidney Transplant Patients'. Together they form a unique fingerprint.

Cite this